510(k) Report

510(k) · Cleared

Cleared

Flex Arm Retractor System

K071338510(k) TraditionalCleared May 29, 200715-day reviewClass II21 CFR 882.4800

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Koros USA, Inc. · GZT Retractor, Self-Retaining, For Neurosurgery

Cleared on May 29, 2007 after a 15-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
May 29, 2007
Review
15 days
Class
Class II
Product code
GZT
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K071338Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZT device

  1. #1 K252995 Durashield Device Kitscore 12.6 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All GZT devices

GZT Retractor, Self-Retaining, For Neurosurgery: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · GZT

1in 2022

2007: 22009: 12010: 12011: 12012: 22015: 12016: 12017: 32018: 12020: 12021: 12022: 12026 (partial year): 1
2007high 3 (2017) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZT

280in 2017

2017: 280 days median
2007high 280 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZT

1in 2012

2007: 12012: 1, 1 Class I
2007high 1 (2007) · low 0 (2008)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GZT

1in 2025

2009: 12010: 42011: 42012: 62013: 122014: 162015: 42016: 52017: 92018: 32019: 52020: 32021: 22022: 42023: 22024: 82025: 1
2007high 16 (2014) · low 0 (2007)2025

MAUDE reports naming product code GZT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—10
20080—00
20091—01
20101—04
20111—04
20122—1 (1)6
20130—012
20140—016
20151—04
20161—05
2017328009
20181—03
20190—05
20201—03
20211—02
20221—04
20230—02
20240—08
20250—01
20261—0—

What is it indicated for?

Flex Arm Retractor System intended to provide surgeons with instruments such as retractors, dilators, probes, protecting shield to perform a variety of neurological procedures utilizing MR visualization. The device may be used in surgical procedures requiring dissection and retraction of tissue. It is intended to be used by trained medical professional in operating room environment.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K071338: Flex Arm Retractor System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K071338

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026